Minodronic acid

Minodronic acid
Names
	Preferred IUPAC name [1-Hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-diyl]bis(phosphonic acid)
	Other names Minodronate; YM 529
Identifiers
CAS Number	180064-38-4 ; 155648-60-5 (monohydrate) ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL319144 ;
ChemSpider	115805 ;
IUPHAR/BPS	3164;
PubChem CID	130956;
UNII	40SGR63TGL ; 457X74V7ND (monohydrate) ;
CompTox Dashboard (EPA)	DTXSID4048779 ;
	InChI InChI=1S/C9H12N2O7P2/c12-9(19(13,14)15,20(16,17)18)5-7-6-10-8-3-1-2-4-11(7)8/h1-4,6,12H,5H2,(H2,13,14,15)(H2,16,17,18) Key: VMMKGHQPQIEGSQ-UHFFFAOYSA-N ;
	SMILES O=P(O)(O)C(O)(P(=O)(O)O)Cc1cnc2ccccn12;
Properties
Chemical formula	C9H12N2O7P2
Molar mass	322.150 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

Minodronic acid is a third-generation bisphosphonate drug. It is approved for use in Japan for the treatment of osteoporosis. Its mechanism of action involves inhibition of farnesyl pyrophosphate synthase activity.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.